|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$1.47 0.00 (0.00%) as of 4:30 Thu 8/11
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
52 |
|
|
Total
Direct Shares :
|
48,246,127 |
|
Total
Indirect Shares :
|
98,277,407 |
|
%
Held by Insiders:
|
46.44% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Agarwal Shefali |
See Remarks |
2022-08-12 |
0 |
2019-01-24 |
0 |
Allen Andrew R |
Director |
2021-06-11 |
20,560 |
2020-03-16 |
0 |
Amgen Inc |
10% Owner |
2013-06-05 |
334,126 |
2013-06-05 |
0 |
Astellas Venture Management Llc |
10% Owner |
2013-06-05 |
650,253 |
2013-06-05 |
0 |
Barrett M James |
10% Owner |
2014-08-15 |
0 |
2016-01-12 |
6,260,851 |
Barris Peter J |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,261,599 |
Baskett Forest |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,260,851 |
Bate Kenneth |
Director |
2022-08-12 |
0 |
2021-06-11 |
0 |
Bay City Capital Fund V, L.p. |
10% Owner |
2014-02-10 |
0 |
2014-02-10 |
3,192,062 |
Bay City Capital Management V Llc |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
3,380,951 |
Bazemore Robert B |
President & CEO, Director |
2021-03-25 |
322,626 |
2016-08-31 |
0 |
Beaulieu Joseph |
See Remarks |
2022-08-12 |
0 |
|
0 |
Beveridge Roy A |
Director |
2022-08-12 |
0 |
2021-11-16 |
0 |
Bogle Grant C. |
President and CEO, Director |
2022-08-12 |
0 |
2021-06-11 |
0 |
Celgene Corp /de/ |
10% Owner |
2014-02-10 |
3,674,640 |
2013-06-05 |
0 |
Conroy Kevin T |
Director |
2022-08-12 |
0 |
2018-07-02 |
0 |
Copeland Robert A |
President of Research and CSO |
2017-06-06 |
31,538 |
2014-08-18 |
0 |
Drant Ryan D |
10% Owner |
2014-08-15 |
0 |
2014-08-15 |
406,500 |
Fleming Suzanne |
|
|
0 |
|
0 |
Gadicke Ansbert |
10% Owner |
|
0 |
2014-02-10 |
2,413,819 |
Garbacz Stephen |
Principal Accounting Officer |
2014-11-03 |
13,073 |
|
0 |
Giordano Michael F |
Director |
2022-08-12 |
0 |
|
0 |
Goldfischer Carl |
Director |
2022-08-12 |
0 |
2022-08-12 |
0 |
Gould Robert J |
Director |
2015-12-30 |
0 |
2014-01-02 |
0 |
Hedrick Eric |
Chief Medical Officer |
2014-10-15 |
429 |
2014-02-10 |
0 |
Ho Peter Tai-Ching |
Chief Development Officer |
2017-10-24 |
8,123 |
2017-10-24 |
2,000 |
Horvitz H Robert |
10% Owner |
2013-05-30 |
161,876 |
2013-05-30 |
24,660 |
Kailian Vaughn M |
10% Owner |
|
0 |
2014-02-10 |
2,413,819 |
Kerins Patrick J |
10% Owner |
2016-01-12 |
651 |
2016-01-12 |
6,260,851 |
Kleiner Perkins Caufield & Byers Xiii, Llc |
10% Owner |
2014-02-10 |
3,838,167 |
2014-02-10 |
0 |
Kolluri Krishna Kittu |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,260,851 |
Kpcb Xiii Associates, Llc |
10% Owner |
2013-06-05 |
4,226,751 |
2013-06-05 |
0 |
Kutok Jeffery |
Chief Scientific Officer |
2022-08-12 |
0 |
2020-04-01 |
0 |
Mott David M |
Director |
2022-08-12 |
0 |
2022-08-12 |
0 |
Nea 13 Gp, Ltd |
10% Owner |
2016-01-12 |
6,260,851 |
2014-08-14 |
406,500 |
New Enterprise Associates 13 Lp |
10% Owner |
2014-08-14 |
5,149,740 |
2014-08-14 |
0 |
Pops Richard F |
Director |
2013-05-30 |
60,000 |
|
0 |
Rhodes Jason P |
President, CFO and Treasurer |
2014-09-22 |
138,000 |
2014-01-06 |
0 |
Richon Victoria |
Director |
2022-08-12 |
0 |
|
0 |
Ros Matthew |
See Remarks |
2021-08-16 |
111,313 |
2017-02-28 |
0 |
Royalty Pharma Investments 2019 Icav |
Director, 10% Owner |
2022-01-31 |
22,666,667 |
2022-08-12 |
0 |
Rpi Finance Trust |
10% Owner |
|
0 |
2022-01-31 |
31,833,334 |
Sandell Scott D |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,261,502 |
Seidenberg Beth C |
Director |
2019-06-30 |
8,481 |
2019-06-30 |
4,115,555 |
Shiosaki Kazumi |
Director |
2013-05-30 |
246,666 |
|
0 |
Singer Andrew E. |
EVP & CFO |
2017-08-09 |
45,446 |
2016-02-09 |
0 |
Stuckley Carol |
Director |
2022-08-12 |
0 |
2021-11-16 |
0 |
Tombesi Paolo |
Chief Financial Officer |
2021-02-04 |
53,465 |
2020-01-23 |
0 |
Vakiener Victoria |
Chief Commercial Officer |
2021-02-04 |
52,685 |
|
0 |
Viswanathan Ravi |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,260,851 |
Weller Harry R |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,260,851 |
Zhang Yi |
10% Owner |
2013-05-30 |
170,000 |
|
0 |
|
|